Back

Cardiomyocyte fusion as a new mechanism contributing to pathological cardiac hypertrophy

29 April 2022 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 1 Cardiac Hypertrophy CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Andrea Colliva

International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste (Italy)

73 More presentations in this session

Presentation thumbnail
Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients
Miss E. Bevilacqua (Seville, ES)
Abstract
Presentation thumbnail
Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring
Doctor K. Viligorska (Chernivtsi, UA)
Abstract
Presentation thumbnail
Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study
Mr C. Rios Navarro (Valencia, ES)
Abstract
Presentation thumbnail
Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion
Associate Professor L. Tacu (Chisinau, MD)
Presentation thumbnail
Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets
Doctor B. Agg (Budapest, HU)
Abstract

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

29 April 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The human cell atlas of the hypertrophic heart reveals impaired inter-cellular cross-talks
27 August 2021
thumbnail
Congress Presentation
The effect of mechanical stretch on phospolamban mutated (PLN-R14del) cardiomyocytes
21 May 2023
thumbnail
Congress Presentation
Testosterone promote myocardial hypertrophy in postmenopausal hypertensive women by regulating the plasma membrane transition of the cardiomyocytes.
1 September 2025
thumbnail
Congress Presentation
Pathogenic mechanism of DSG2-F531C mutation caused arrhythmogenic right ventricular cardiomyopathy
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources